The influence of radiographic phenotype and smoking status on peripheral blood biomarker patterns in chronic obstructive pulmonary disease

PLoS ONE

Volumn 4, Issue 8, 2009, Pages

  Bon, Jessica M ^a   Leader, Joseph K ^a   Weissfeld, Joel L ^b   Coxson, Harvey O ^c   Zheng, Bin ^a   Branch, Robert A ^d   Kondragunta, Venkateswarlu ^d   Lee, Janet S ^a   Zhang, Yingze ^a   Choi, Augustine M K ^e   Lokshin, Anna E ^f   Kaminski, Naftali ^a   Gur, David ^a   Sciurba, Frank C ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PITTSBURGH GRADUATE SCHOOL OF PUBLIC HEALTH   (United States)

^c VANCOUVER GENERAL HOSPITAL   (Canada)

^d UNIVERSITY OF PITTSBURGH   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CYTOKINE; EOTAXIN; EPIDERMAL GROWTH FACTOR RECEPTOR; GAMMA INTERFERON; GELATINASE A; GROWTH FACTOR; INTERLEUKIN 13; INTERLEUKIN 2 RECEPTOR; INTERLEUKIN 6; INTERSTITIAL COLLAGENASE; MATRILYSIN; RANTES; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR RECEPTOR 2;

ADULT; AGED; AIRWAY OBSTRUCTION; ARTICLE; BLOOD ANALYSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FORCED EXPIRATORY VOLUME; HUMAN; LUNG EMPHYSEMA; LUNG PARENCHYMA; LUNG VOLUME; MAJOR CLINICAL STUDY; MALE; PHENOTYPE; PROTEIN BLOOD LEVEL; PROTEIN MICROARRAY; QUANTITATIVE ANALYSIS; RADIODIAGNOSIS; RESPIRATORY TRACT PARAMETERS; SMOKING HABIT; BLOOD; COHORT ANALYSIS; MIDDLE AGED; PATHOPHYSIOLOGY; RADIOGRAPHY; SMOKING;

AGED; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; FORCED EXPIRATORY VOLUME; HUMANS; MALE; MIDDLE AGED; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; SMOKING; TOMOGRAPHY, X-RAY COMPUTED;

EID: 69949189204     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0006865     Document Type: Article

References (45)

1. Gelb AF, Schein MJ, Kuei J, Tashkin DP, Muller NL, et al. (1993) Limited Contribution of Emphysema in Advanced Chronic Obstructive Pulmonary Disease. American Review of Respiratory Disease 147: 1157-1161.
2. Nakano Y, Muller NL, King GG, Niimi A, Kalloger SE, et al. (2002) Quantitative assessment of airway remodeling using high-resolution CT. Chest 122: 271S-275S.
3. Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, et al. (2004) The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease. N Engl J Med 350: 2645-2653.
4. MacNee W (2005) Pathogenesis of Chronic Obstructive Pulmonary Disease. Proc Am Thorac Soc 2: 258-266.
5. Agusti AGN, Noguera A, Sauleda J, Sala E, Pons J, et al. (2003) Systemic effects of chronic obstructive pulmonary disease. Eur Respir J 21: 347-360.
6. Barnes PJ, Shapiro SD, Pauwels RA (2003) Chronic obstructive pulmonary disease: molecular and cellular mechanisms. Eur Respir J 22: 672-688.
7. Barnes PJ (2004) Mediators of Chronic Obstructive Pulmonary Disease. Pharmacol Rev 56: 515-548.
8. McNitt-Gray MF, Goldin JG, Johnson TD, Tashkin DP, Aberle DR (1997) Development and testing of image-processing methods for the quantitative assessment of airway hyperresponsiveness from high-resolution CT images. J Comput Assist Tomogr 21: 939-947.
9. Muller N, Staples C, Miller R, Abboud R (1988) 'Density Mask'. An objective method to quantitate emphysema using computed tomography. Chest 94: 782-787.
10. Nakano Y, Wong JC, de Jong PA, Buzatu L, Nagao T, et al. (2005) The prediction of small airway dimensions using computed tomography. Am J Respir Crit Care Med 171: 142-146.
11. Nakano Y, Muro S, Sakai H, Hirai T, Chin K, et al. (2000) Computed tomographic measurements of airway dimensions and emphysema in smokers. Correlation with lung function. Am J Respir Crit Care Med 162: 1102-1108.
12. (1991) Lung function testing: selection of reference values and interpretative strategies. American Thoracic Society. Am Rev Respir Dis 144: 1202-1218.
13. (1995) Standardization of spirometry, 1994 update. American Thoracic Society. Am J Respir Crit Care Med 152: 1107-1136.
14. Hankinson JL, Odencrantz JR, Fedan KB (1999) Spirometric Reference Values from a Sample of the General U.S. Population. Am J Respir Crit Care Med 159: 179-187.
15. McNitt-Gray MF, Goldin JG, Johnson TD, Tashkin DP, Aberle DR (1997) Development and testing of image-processing methods for the quantitative assessment of airway hyperresponsiveness from high-resolution CT images. J Comput Assist Tomogr 21: 939-947.
16. Nakano Y, Muro S, Sakai H, Hirai T, Chin K, et al. (2000) Computed Tomographic Measurements of Airway Dimensions and Emphysema in Smokers. Correlation with Lung Function. Am J Respir Crit Care Med 162: 1102-1108.
17. Leader J, Zheng B, Sciurba F, Coxson H, Fuhrman C, et al. (2007) Quantification of airway morphometry: the effect of CT acquisition and reconstruction parameters. Proc SPIE 6511: 1R-1 to 1R-7.
18. Zheng B, Leader J, McMurray J, Park S, Fuhrman C, et al. (2007) Automated detection and quantitative assessment of pulmonary airways depicted on CT images. Med Phys 34: 2844-2852.
19. Leader J, Zheng B, Rogers R, Sciurba F, Perez A, et al. (2003) Automated lung segmentation in x-ray computed tomography: development and evaluation of a heuristic threshold-based scheme. Acad Radiol 10: 1224-1236.
20. Gorelik E, Landsittel DP, Marrangoni AM, Modugno F, Velikokhatnaya L, et al. (2005) Multiplexed immunobead-based cytokine profiling for early detection of ovarian cancer. Cancer Epidemiol Biomarkers Prev 14: 981-987.
21. Schols AM, Buurman WA, Staal van den Brekel AJ, Dentener MA, Wouters EF (1996) Evidence for a relation between metabolic derangements and increased levels of inflammatory mediators in a subgroup of patients with chronic obstructive pulmonary disease. Thorax 51: 819-824.
22. Eid AA, Ionescu AA, Nixon LS, Lewis-Jenkins V, Matthews SB, et al. (2001) Inflammatory Response and Body Composition in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med 164: 1414-1418.
23. Pinto-Plata V, Toso J, Lee K, Park D, Bilello J, et al. (2007) Profiling serum biomarkers in patients with COPD: associations with clinical parameters. Thorax 62: 595-601.
24. Hersh CP, DeMeo DL, Lazarus R, Celedon JC, Raby BA, et al. (2006) Genetic Association Analysis of Functional Impairment in Chronic Obstructive Pulmonary Disease. Am J Respir Crit Care Med. 200509-201452OC.
25. Lee JS, Rosengart MR, Kondragunta V, Zhang Y, McMurray J, et al. (2007) Inverse association of plasma IL-13 and inflammatory chemokines with lung function impairment in stable COPD: a cross-sectional cohort study. Respir Res 8: 64.
26. Nakano Y, Wong JC, de Jong PA, Buzatu L, Nagao T, et al. (2005) The Prediction of Small Airway Dimensions Using Computed Tomography. Am J Respir Crit Care Med 171: 142-146.
27. Hogg JC, Macklem PT, Thurlbeck WM (1968) Site and nature of airway obstruction in chronic obstructive lung disease. N Engl J Med 278: 1355-1360.
28. Patel BD, Coxson HO, Pillai SG, Agusti AG, Calverley PM, et al. (2008) Airway Wall Thickening and Emphysema Show Independent Familial Aggregation in COPD. Am J Respir Crit Care Med.
29. Shapiro SD (2001) End-Stage Chronic Obstructive Pulmonary Disease. The Cigarette Is Burned out but Inflammation Rages on. Am J Respir Crit Care Med 164: 339-340.
30. Drannik AG, Pouladi MA, Robbins CS, Goncharova SI, Kianpour S, et al. (2004) Impact of Cigarette Smoke on Clearance and Inflammation after Pseudomonas aeruginosa Infection. Am J Respir Crit Care Med 170: 1164-1171.
31. Zhang J, Liu Y, Shi J, Larson DF, Watson RR (2002) Side-Stream Cigarette Smoke Induces Dose-Response in Systemic Inflammatory Cytokine Production and Oxidative Stress. Experimental Biology and Medicine 227: 823-829.
32. Wannamethee SG, Lowe GDO, Shaper AG, Rumley A, Lennon L, et al. (2005) Associations between cigarette smoking, pipe/cigar smoking, and smoking cessation, and haemostatic and inflammatory markers for cardiovascular disease. Eur Heart J 26: 1765-1773.
33. Thakore AH, Guo C-Y, Larson MG, Corey D, Wang TJ, et al. (2007) Association of Multiple Inflammatory Markers with Carotid Intimal Medial Thickness and Stenosis (from the Framingham Heart Study). The American Journal of Cardiology 99: 1598-1602.
34. He J-Q, Burkett K, Connett J, Anthonisen N, Paré P, et al. (2006) Interferon gamma polymorphisms and their interaction with smoking are associated with lung function. Human Genetics 119: 365-375.
35. Sadeghnejad A, Meyers DA, Bottai M, Sterling DA, Bleecker ER, et al. (2007) IL13 Promoter Polymorphism 1112C/T Modulates the Adverse Effect of Tobacco Smoking on Lung Function. Am J Respir Crit Care Med 176: 748-752.
36. Kim EY, Battaile JT, Patel AC, You Y, Agapov E, et al. (2008) Persistent activation of an innate immune response translates respiratory viral infection into chronic lung disease. Nat Med 14: 633-640.
37. Feghali-Bostwick CA, Gadgil AS, Otterbein LE, Pilewski JM, Stoner MW, et al. (2008) Autoantibodies in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med 177: 156-163.
38. Sethi S, Wrona C, Eschberger K, Lobbins P, Cai X, et al. (2008) Inflammatory profile of new bacterial strain exacerbations of chronic obstructive pulmonary disease. Am J Respir Crit Care Med 177: 491-497.
39. Hoshino T, Kato S, Oka N, Imaoka H, Kinoshita T, et al. (2007) Pulmonary Inflammation and Emphysema: Role of the Cytokines IL-18 and IL-13. Am J Respir Crit Care Med 176: 49-62.
40. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, et al. (1999) Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 103: 779-788.
41. van der Pouw Kraan T, Kucukaycan M, Bakker A, Baggen J, van der Zee J, et al. (2002) Chronic obstructive pulmonary disease is associated with the -1055 IL-13 promoter polymorphism. Genes and Immunity 3: 436-439.
42. Muller V, Witzel I, Pantel K, Krenkel S, Luck HJ, et al. (2006) Prognostic and predictive impact of soluble epidermal growth factor receptor (sEGFR) protein in the serum of patients treated with chemotherapy for metastatic breast cancer. Anticancer Res 26: 1479-1487.
43. Lemos-Gonzalez Y, Rodriguez-Berrocal FJ, Cordero OJ, Gomez C, Paez de la Cadena M (2007) Alteration of the serum levels of the epidermal growth factor receptor and its ligands in patients with non-small cell lung cancer and head and neck carcinoma. Br J Cancer 96: 1569-1578.
44. Mouawad R, Soubrane C, Rixe O, Khayat D, Spano JP (2006) An unexpected inverse correlation between soluble epidermal growth factor receptor and interleukin-6 in metastatic malignant melanoma patients. Melanoma Res 16: 335-340.
45. Vestbo J, Anderson W, Coxson HO, Crim C, Dawber F, et al. (2008) Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points (ECLIPSE). Eur Respir J 31: 869-873.